James J Ignatz-Hoover

5PUBLICATIONS
13CO-AUTHORS
Medical parasitologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 16, 2025
Serological pseudoprogression of multiple myeloma after treatment with teclistamab.

Michael Daunov, Ibrahim Alagha, Arash Rashidi

|Aug 30, 2024
Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity.

Priyanka S Rana, James J Ignatz-Hoover, Chunna Guo

|Aug 27, 2024
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial.

Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas

|May 15, 2024
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity.

Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim

|Nov 03, 2018
Aberrant GSK3β nuclear localization promotes AML growth and drug resistance.

James J Ignatz-Hoover, Victoria Wang, Nathan M Mackowski

Pageof 1

Frequent Collaborators

3 joint publications

Priyanka S Rana

3 joint publications

James J Driscoll

2 joint publications

Ehsan Malek

2 joint publications

Yuriy Federov